Vistagen Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Boosts Investor Sentiment GECCI Q1 2026 Earnings Strong EPS Beat Driven by Robust Investment Income Palo Alto Networks PANW Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses A2Z Cust2Mate Solutions Corp AZ Q3 2025 Earnings Loss Per Share of 007 as Company Continues Platform Investments Stock Moves Higher Ernexa Therapeutics ERNA Q3 2023 Earnings ClinicalStage Biotech Reports Net Loss as Stock Declines